Who has invested in Ambrx?

5AM Ventures, Tavistock Life Sciences are named among the investors backing Ambrx.

Ambrx Funding: $346M Raised, Investors & Rounds

Ambrx funding overview

Ambrx is based in San Diego, CA. Ambrx has raised $346M in total disclosed funding. That places its disclosed total in the $250M–$1B range. The round record for Ambrx runs through 2024; nothing later has been disclosed. Investors on record include 5AM Ventures, Tavistock Life Sciences. 2 distinct backers are named across the disclosed rounds.

Ambrx at a glance

Total raised: $346M
Latest round date: January 2024
Headquarters: San Diego, CA
Notable investors: 5AM Ventures, Tavistock Life Sciences

Frequently asked about Ambrx funding

How much has Ambrx raised?: Ambrx has raised $346M in total disclosed funding across the rounds on record.
Who has invested in Ambrx?: 5AM Ventures, Tavistock Life Sciences are named among the investors backing Ambrx.
What was the latest Ambrx funding round?: No round stage has been disclosed for Ambrx.
Where is Ambrx based?: Ambrx is based in San Diego, CA.
When did Ambrx last raise?: The last disclosed Ambrx round closed in January 2024.

We update the Ambrx record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in San Diego and their backers are listed below.

Ambrx Funding: $346M Raised, Investors & Rounds

Ambrx funding overview

Ambrx at a glance

Frequently asked about Ambrx funding

Companies related to Ambrx (36)

Browse related funding lists (5)